Noopem 1g IV Injection by Nicholas Pharmaceuticals

Noopem 1g IV Injection by Nicholas Pharmaceuticals contains Meropenem 1g, a broad-spectrum carbapenem antibiotic supplied as sterile powder for intravenous administration. It is a prescription antibacterial medicine used by healthcare professionals for the treatment of certain serious bacterial infections caused by susceptible microorganisms. The supplied pack contains 1 vial of 1g meropenem with 20ml sterile water for injection as diluent, as shown on the product packaging. Nicholas Pharma’s product listing also identifies Noopem 1gm Injection IV as Meropenem 1gm.

Meropenem may be used for conditions including complicated intra-abdominal infections and complicated skin and skin-structure infections, with specific approved uses varying by age, indication, and local prescribing information. It is also used for certain bacterial meningitis cases in pediatric patients according to approved labeling. Meropenem should only be used when a susceptible bacterial infection is proven or strongly suspected and should be administered by a qualified healthcare professional.

Key Benefits

• Contains Meropenem 1g
• Broad-spectrum carbapenem antibiotic
• Intended for intravenous administration
• Used for certain serious bacterial infections
• Suitable for hospital and clinical use under medical supervision
• Supplied as sterile powder for injection
• Pack includes sterile water for injection as diluent, as shown on the supplied packaging

How It Works

Meropenem belongs to the carbapenem class of antibacterial medicines. It works by interfering with bacterial cell-wall synthesis, which inhibits the growth of susceptible bacteria. Its broad antibacterial activity makes it useful in the management of selected serious infections when prescribed appropriately.

The choice of meropenem should be based on the suspected or confirmed causative bacteria, infection site, local resistance patterns, and clinical judgment. Appropriate antibiotic selection helps reduce the development of antimicrobial resistance.

Directions for Use

• For intravenous use only.
• Meropenem must be reconstituted and administered by a qualified healthcare professional.
• The dose and treatment duration depend on the type and severity of infection, the patient’s age, kidney function, and clinical response.
• Adult dosing varies by indication; official prescribing information includes 500mg every 8 hours for certain complicated skin/skin-structure infections and 1g every 8 hours for certain intra-abdominal infections.
• Dosage adjustment is required in adults with significant renal impairment.
• Do not self-administer or use without a physician’s prescription.

Precautions

• Noopem is a prescription antibiotic and should only be administered under medical supervision.
• Do not use in patients with known serious hypersensitivity to meropenem or certain other beta-lactam antibiotics.
• Tell the doctor about any previous allergy to penicillins, cephalosporins, carbapenems, or other beta-lactam antibiotics.
• Inform the healthcare professional about kidney disease because dosage adjustment may be necessary.
• Meropenem may interact with valproic acid or divalproex sodium, potentially reducing valproic acid concentrations and increasing seizure risk.
• Serious allergic reactions, severe skin reactions, seizures, and antibiotic-associated diarrhea have been reported with meropenem.
• Antibiotics should only be used for bacterial infections and should not be used unnecessarily for viral infections.
• Keep out of reach of children.

Storage Instructions

Store Noopem 1g IV Injection according to the storage conditions specified on the current product packaging and approved prescribing information. Keep the unopened vial in its original packaging and protect it from inappropriate heat, light, and moisture. Reconstituted solution should be handled and stored only according to the manufacturer’s preparation and stability instructions by qualified healthcare personnel.

Manufacturer Information

Noopem 1g IV Injection is manufactured by Nicholas Pharmaceuticals. Nicholas Pharma’s official product listing identifies Noopem 1gm Injection IV as Meropenem 1gm.

Noopem 1g Injection is a pharmaceutical product containing Meropenem, which is a broad-spectrum antibiotic used to treat a variety of serious bacterial infections. Meropenem is part of the carbapenem class of antibiotics and works by inhibiting the growth of bacteria, preventing them from forming cell walls, which ultimately leads to bacterial cell death. It is particularly effective against both Gram-positive and Gram-negative bacteria, including those that are resistant to other antibiotics.

Noopem 1g Injection is typically administered intravenously (IV) and is used to treat infections such as those in the respiratory tract, urinary tract, intra-abdominal infections, skin and soft tissue infections, and in some cases, bacterial meningitis.

INGRIDENTS

MEROPENEM